Cargando…

Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen

BACKGROUND: Virus-like particles (VLPs) can be efficiently produced by heterologous expression of viral structural proteins in yeast. Due to their repetitive structure, VLPs are extensively used for protein engineering and generation of chimeric VLPs with inserted foreign epitopes. Hamster polyomavi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pleckaityte, Milda, Bremer, Corinna M., Gedvilaite, Alma, Kucinskaite-Kodze, Indre, Glebe, Dieter, Zvirbliene, Aurelija
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570255/ https://www.ncbi.nlm.nih.gov/pubmed/26370129 http://dx.doi.org/10.1186/s12896-015-0203-3

Ejemplares similares

Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin
por: Pleckaityte, Milda, et al.
Publicado: (2011)

Immunogenic Properties and Antigenic Similarity of Virus-like Particles Derived from Human Polyomaviruses
por: Lučiūnaitė, Asta, et al.
Publicado: (2023)

Activation of NLRP3 Inflammasome by Virus-Like Particles of Human Polyomaviruses in Macrophages
por: Lučiūnaitė, Asta, et al.
Publicado: (2022)

Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes
por: Gedvilaite, Alma, et al.
Publicado: (2015)

Mapping of Recognition Sites of Monoclonal Antibodies Responsible for the Inhibition of Pneumolysin Functional Activity
por: Kucinskaite-Kodze, Indre, et al.
Publicado: (2020)

The Use of Chimeric Virus-like Particles Harbouring a Segment of Hantavirus Gc Glycoprotein to Generate a Broadly-Reactive Hantavirus-Specific Monoclonal Antibody
por: Zvirbliene, Aurelija, et al.
Publicado: (2014)

Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage
por: Sereikaitė, Emilija, et al.
Publicado: (2023)

The Use of Recombinant Pseudotype Virus-Like Particles Harbouring Inserted Target Antigen to Generate Antibodies against Cellular Marker p16(INK4A)
por: Lasickienė, Rita, et al.
Publicado: (2012)

Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection
por: Kučinskaitė-Kodzė, Indrė, et al.
Publicado: (2021)

Insights into the CRISPR/Cas system of Gardnerella vaginalis
por: Pleckaityte, Milda, et al.
Publicado: (2012)

Generation of recombinant single-chain antibodies neutralizing the cytolytic activity of vaginolysin, the main virulence factor of Gardnerella vaginalis
por: Pleckaityte, Milda, et al.
Publicado: (2011)

The Cytolytic Activity of Vaginolysin Strictly Depends on Cholesterol and Is Potentiated by Human CD59
por: Zilnyte, Milda, et al.
Publicado: (2015)

Production of recombinant VP1-derived virus-like particles from novel human polyomaviruses in yeast
por: Norkiene, Milda, et al.
Publicado: (2015)

Reconstitution of Cholesterol-Dependent Vaginolysin into Tethered Phospholipid Bilayers: Implications for Bioanalysis
por: Budvytyte, Rima, et al.
Publicado: (2013)

Characterization of a Panel of Cross-Reactive Hantavirus Nucleocapsid Protein-Specific Monoclonal Antibodies
por: Avižinienė, Aliona, et al.
Publicado: (2023)

Electrochemical Determination of Interaction between SARS-CoV-2 Spike Protein and Specific Antibodies
por: Drobysh, Maryia, et al.
Publicado: (2022)

Vaccination with Prion Peptide-Displaying Polyomavirus-Like Particles Prolongs Incubation Time in Scrapie-Infected Mice
por: Eiden, Martin, et al.
Publicado: (2021)

Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies
por: Nainys, Juozas, et al.
Publicado: (2014)

Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope
por: Mazeike, Egle, et al.
Publicado: (2012)

Activation of Macrophages by Oligomeric Proteins of Different Size and Origin
por: Dalgėdienė, Indrė, et al.
Publicado: (2018)

Molecular characteristics of Neisseria meningitidis carriage strains in university students in Lithuania
por: Ivaškevičienė, Inga, et al.
Publicado: (2023)

A Human Monoclonal Antibody against Hepatitis B Surface Antigen with Potent Neutralizing Activity
por: Cerino, Antonella, et al.
Publicado: (2015)

Type II Restriction-Modification System from Gardnerella vaginalis ATCC 14018
por: Bulavaitė, Aistė, et al.
Publicado: (2020)

Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles
por: Moeschler, Sarah, et al.
Publicado: (2016)

Generation of Recombinant Schmallenberg Virus Nucleocapsid Protein in Yeast and Development of Virus-Specific Monoclonal Antibodies
por: Lazutka, Justas, et al.
Publicado: (2014)

Characterization of the GBoV1 Capsid and Its Antibody Interactions
por: Yu, Jennifer Chun, et al.
Publicado: (2021)

Hamster Polyomavirus Research: Past, Present, and Future §
por: Jandrig, Burkhard, et al.
Publicado: (2021)

Nipah Virus Infection Generates Ordered Structures in Cellulo
por: Vázquez, Cecilia Alejandra, et al.
Publicado: (2022)

Development of a neutralization assay based on the pseudotyped chikungunya virus of a Korean isolate
por: Chung, Woo-Chang, et al.
Publicado: (2019)

Influence of Codon Bias on Heterologous Production of Human Papillomavirus Type 16 Major Structural Protein L1 in Yeast
por: Norkiene, Milda, et al.
Publicado: (2012)

Inactivation Methods for Experimental Nipah Virus Infection
por: Widerspick, Lina, et al.
Publicado: (2022)

Package of NDV-Pseudotyped HIV-Luc Virus and Its Application in the Neutralization Assay for NDV Infection
por: Wang, Bin, et al.
Publicado: (2014)

Neutralizing Antibody to Vesicular Stomatitis Virus (HTLV‐I) Pseudotype in Infants Born to Seropositive Mothers
por: Iwahara, Yoshihito, et al.
Publicado: (1993)

Development of in vitro and in vivo neutralization assays based on the pseudotyped H7N9 virus
por: Tian, Yabin, et al.
Publicado: (2018)

Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype
por: Mercier-Delarue, Séverine, et al.
Publicado: (2017)

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
por: Schmidt, Fabian, et al.
Publicado: (2020)

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
por: Lei, Changhai, et al.
Publicado: (2020)

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
por: Schmidt, Fabian, et al.
Publicado: (2020)

Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum
por: Pipperger, Lisa, et al.
Publicado: (2019)

The use of pseudotypes to study viruses, virus sero-epidemiology and vaccination()
por: Bentley, Emma M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jcqlikp73snj4ke2gk9lijg23q